294
Malignant melanoma occurred in maxillary sinus: case
report with review of literature
S.H. Shin
∗
, S.G. Kim
Department of Oral and Maxillofacial Surgery, College of
Dentistry, Gangneung-Wonju National University, Gangneung,
Republic of Korea
Background:
Malignant melanoma occurred in sinonasal mucosa
is rare malignancy. It accounts for less than 1% of all malignant
melanoma. In most of cases, it occurs primarily in mucosa of
nasal cavity. However, in some rare cases, paranasal sinus can be
primary place of malignant melanoma.
Objectives:
The purpose of this report is to introduce a case of a
patient who had malignant melanoma which occurred primarily
on maxillary sinus.
Methods:
The patient with malignant melanoma on maxillary
sinus visited our clinic. Considering age and personal circum-
stances of patient, we removed tumour without safety margin
and fat pad graft was done for covering bony defect. After
stitch-out, the patient was referred to haemato-oncology for addi-
tional radiation therapy or chemotherapy. For review of literature,
PubMed was searched with keywords of maxillary sinus and
malignant melanoma. On the result, the literatures about malignant
melanoma occurred in nasal cavity primarily were excluded.
Findings and Conclusion:
Malignant melanoma occurred in
maxillary sinus showed aetiologic, histological features and sur-
vival rate that are quite different with skin malignant melanoma.
http://dx.doi.org/10.1016/j.ijom.2017.02.989Perioperative management of head and neck cancer patients
among United States of America maxillofacial units
M. Siew
∗
, S. Chandra
University of Washington, Seattle, United States
Background:
Oncologic and microvascular reconstruction in
oral/maxillofacial surgery has broadened treatment options and
improved aesthetic and functional outcomes. However, evidence-
based guidelines for perioperative management of head-and-neck
cancer patients are meagre. By delineating contemporary surgical
practices, we hope to facilitate consensus among head-and-neck
specialists on evidence-based treatments that improve outcomes
and reduce length-of-stay and hospital expenses.
Objectives:
To assess variation among United States of America
(USA) maxillofacial units concerning perioperative management
of head-and-neck cancer patients, determine whether current prac-
tices conform to published evidence in literature, and present an
evidence-based clinical care pathway.
Methods:
Maxillofacial units performing oncologic and
microvascular reconstructive surgery in the USA were surveyed
with nominal/ordinal multiple-choice, matrix, and free response
questions. Descriptive analysis was performed.
Findings:
30% response rate is comparable to published studies.
66.1% often/always submit biopsy specimens for second review.
81.1% have no preference regarding order of imaging/biopsy.
Intraoperatively, 47.9% often/always avoid vasopressors, and
25% always use aspirin intraoperatively while 41.7% never do.
72.4% rarely/never place implants intraoperatively. Postopera-
tively, 77.1% often/always provide intensive care unit care and
60.4% position at neutral and/or 30 degrees elevated. 64.6%
often/always perform elective tracheostomies. In addition to clin-
ical observation, adjunctive flap monitoring primarily involves
surface and invasive Doppler.
Conclusion:
Our survey is the only large-scale study of care prac-
tices among USA maxillofacial units performing head-and-neck
oncologic surgery and demonstrates areas of agreement and non-
uniformity. More prospective clinical trials are needed to identify
evidence-based clinical practices that improve care and decrease
healthcare costs. A clinical care pathway designed by the senior
author for head-and-neck cancer patients will be presented.
http://dx.doi.org/10.1016/j.ijom.2017.02.990Circulating microparticles levels in the patients of lymphatic
malformations: possible role in the development of lymphatic
malformations
Y. Sun
∗
, J. Ren, B. Liu, Y. Zhao
Hospital of Stomatology, Wuhan University, Wuhan, China
Background:
Microparticles (MPs) are circulating membrane
particles of less than a micrometre in diameter shed from endothe-
lial and blood cells. Recent literature suggests that MPs may
possess biological functions and mediate the communication
between vascular cells. We hypothesised that MPs may have pos-
sible role in the development of lymphatic malformations.
Objectives:
To study the clinical significance of circulating
microparticles levels of the local lesion and peripheral blood in
the patients of lymphatic malformations.
Methods:
Collecting and separating the circulatingmicroparticles
of the local lesion and peripheral blood in the patients of lym-
phatic malformations and the normals. Flow cytometry was used
to test the concentration and the classification of the circulating
microparticles. According to the results combined with clinical
indicators to analyse the clinical significance.
Findings:
Compared with the normals, the total circulating
microparticles levels of peripheral blood in the patients of lym-
phatic malformations were significantly increased. The circulating
microparticles levels of cystic fluid in the local lesions were higher
than those of the peripheral blood in the patients of lymphatic
malformations and the normals, and the classification was also
different. In addition, the circulating microparticles levels of cys-
tic fluid in the local lesions and peripheral blood were significantly
higher in the larger lesions.
Conclusion:
The levels and the classification of the circulating
microparticles in the patients of lymphatic malformations were
different with those in the normals. The circulating microparticles
may contribute to the development of lymphatic malformations.
http://dx.doi.org/10.1016/j.ijom.2017.02.991




